Clinical Research Directory
Browse clinical research sites, groups, and studies.
PEA in Functional Dyspepsia
Sponsor: Universitaire Ziekenhuizen KU Leuven
Summary
The goal of this placebo controlled randomized double blind interventional study is to assess the effect of palmitoylethanolamide supplementation in patients with functional dyspepsia The main questions it aims to answer are: * The efficacy of PEA on functional dyspepsia symptoms measured using the LPDS questionnaire * The effect of PEA on duodenal mucosal permeability. Participants will receive an 8-week during treatment with PEA 3x400 mg per day or placebo 3 times per day.
Official title: THE EFFECT OF DIETARY SUPPLEMENTATION WITH PALMITOYLETHANOLAMIDE ON GASTROINTESTINAL SYMPTOMS IN FUNCTIONAL DYSPEPSIA PATIENTS.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2021-11-29
Completion Date
2025-03-01
Last Updated
2024-07-01
Healthy Volunteers
No
Interventions
Palmitoylethanolamide
8-week treatment 3x400 mg per day
Locations (1)
KU Leuven
Leuven, Vlaams-Brabant, Belgium